Article

Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients hospitalized for COVID-19: a large Spanish cohort study

2021-02-25

Abstract excerpt

<h4>Background</h4> The use of ACEI (Angiotensin-Converting Enzyme Inhibitor) and ARB (Angiotensin II Receptor Blocker) in COVID-19 remains controversial. Our main aim was to describe the effect of ACEI/ARB treatment during COVID-19 hospitalization on mortality and complications. <h4>Methods</h4> Retrospective, observational, multicenter study, part of the SEMI-COVID-19 Registry, comparing patients with COVID-19 t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c2e885ec-cffc-5dc2-b9e6-b60f86435ff1
DOI: 10.1101/2021.02.24.21252391

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients hospitalized for COVID-19: a large Spanish cohort studyDOI 10.1101/2021.02.24.21252391Read

Impact of Renin-Angiotensin-Aldosterone System Inhibition on Mortality in Critically Ill COVID-19 Patients with Pre-Existing Hypertension: A Prospective Cohort StudySemantic proximity Read

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals; Retrospective Cohort StudySemantic proximity Read

Cardiovascular Therapy and Mortality in Hospitalized Patients With COVID-19: A Cohort StudySemantic proximity Read

Mortality and Severity in COVID-19 Patients on ACEIs & ARBs - A Meta-Regression AnalysisSemantic proximity Read

Severity of COVID-19 Infection in ACEI/ARB Users in Two Saudi Public Specialty Hospitals: Retrospective Cohort StudySemantic proximity Read

Epidemiological Risk Factors Associated with Death and Severe Disease in Patients Suffering From COVID-19: A Comprehensive Systematic Review and Meta-analysisSemantic proximity Read

Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBsSemantic proximity Read

ARB/ACEI use and severe COVID-19: a nationwide case-control studySemantic proximity Read

Angiotensin-converting enzyme inhibitors (ACEI) or Angiotensin receptor blockers (ARBs) may be safe for COVID-19 patientsSemantic proximity Read

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort studySemantic proximity Read

Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational studySemantic proximity Read

Association of in-hospital use of ACE-I/ARB and COVID-19 outcomes in African American populationSemantic proximity Read